Using AI in drug discovery

Making in silico drug-target activity predictions

Medicines Discovery Catapult

Dr Charles Bury is a Cheminformatics Data Scientist at Medicines Discovery Catapult.

Before joining us, Charles completed a DPhil in Biochemistry at the University of Oxford, where his research focused primarily on the development of automated tools for radiation damage detection & correction during macromolecular X-ray crystallography (MX) experiments.